United States Antimony Corporation (UAMY)
Live price chart, market sentiment, and community perspectives for United States Antimony Corporation (NYSE: UAMY).
Live price chart, market sentiment, and community perspectives for United States Antimony Corporation (NYSE: UAMY).
On our desk, the sheer scale of the guidance cut from $125 million down to $60M–$75M caught everyone off guard. Even though Q2 revenue rose 17% sequentially to $7.9 million on higher volumes, the 52% collapse in average antimony selling prices down to $13.70 per pound completely obliterated gross margins. We are advising clients to stay sidelined given the severe disconnect between previous expectations and the current reality on the income statement.
Looking at the fundamental metrics from a risk management perspective, the company swung from a net income of $728,079 in the first half of 2025 to a massive net loss of $11.18 million in the first half of 2026. Operating expenses ballooned to $7.6 million, fueled by $2.9 million in share-based compensation and higher staffing and professional fees. With gross margins compressed to just 7%, the downside volatility we are seeing in the stock price is entirely justified.
Watching the market reaction, the 19.3% single-day sell-off reflects profound disappointment after consecutive quarters of price compression. Antimony revenue fell to $5.9 million compared to $9.6 million in the prior year period. Market sentiment has effectively shifted from a growth narrative to a capital preservation mindset, making the upcoming November earnings report a critical make-or-break catalyst for institutional holders.
From a technical and operational protocol standpoint, our primary focus is dissecting how management plans to navigate delayed Defense Logistics Agency (DLA) contract deliveries alongside depressed market pricing. While alternative data shows headcount climbing and user growth holding relatively steady with an AI score of 50, the fundamental score sits at a dismal 13 out of 100. Any upcoming technical evaluations must account for these heavy operational hurdles.
Evaluating the alternative data signals on UAMY, we notice a severe divergence between internal corporate expansion—such as climbing headcount and ongoing North American mining projects—and external financial reality. In our research notes, we emphasize that building inventory for government deliveries offers a minor cushion, but it fails to offset the immediate income statement damage inflicted by falling spot prices.
From our quantitative risk models, the sharp contraction in profitability despite a 26% increase in pounds sold highlights extreme vulnerability to commodity price swings. Gross profit dropped to just $0.6 million with a 7% margin down from 27% a year prior. We are hedging our portfolio exposure by avoiding long-only allocations in UAMY until price stabilization is definitively proven across multiple consecutive reporting periods.
Explore plasma cleansing, somatic organ swaps, and BCI.